Apellis Pharmaceuticals, Inc. (APLS)
Company Info
| ISIN | US03753U1060 |
|---|---|
| CUSIP | 03753U106 |
| Sector | Healthcare |
| Industry | Biotechnology |
Trading Data
| Previous Close | $50.61 |
|---|---|
| Year Range | $35.07 - $68.67 |
| EMA (50) | $51.43 |
| EMA (200) | $50.82 |
| Average Volume | $1.21M |
| Market Capitalization | $5.60B |
APLSShare Price Chart
Loading data...
APLSPerformance
The chart shows the growth of $10,000 invested in Apellis Pharmaceuticals, Inc. in Nov 2017 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $36,073 for a total return of roughly 260.73%. All prices are adjusted for splits and dividends.
APLSCompare to other instruments
APLSReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| YTD | -2.13% | 4.70% |
| 1M | -0.49% | 4.55% |
| 6M | -4.13% | 1.47% |
| 1Y | 42.72% | -8.60% |
| 5Y | 23.10% | 7.21% |
| 10Y | 28.06% | 8.89% |
APLSMonthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -14.83% | 5.61% | 19.47% | -14.33% | -4.78% | 9.10% | 24.46% | 7.52% | 12.87% | -11.43% | -17.46% | 3.56% |
| 2021 | -22.60% | 8.81% | -10.92% | 18.08% | 11.07% | 12.30% | 1.25% | 2.91% | -49.95% | -6.74% | 36.89% | 12.36% |
| 2020 | 34.26% | -15.79% | -22.62% | 27.92% | -1.69% | -3.06% | -20.73% | 19.08% | -2.14% | 5.73% | 47.77% | 21.34% |
| 2019 | 6.14% | 8.21% | 28.71% | 1.59% | 1.41% | 26.13% | 10.22% | 4.19% | -17.22% | 22.00% | -8.54% | 13.91% |
| 2018 | -23.50% | 10.42% | 20.62% | 9.05% | -15.35% | 7.79% | -16.36% | 5.22% | -8.16% | -21.32% | 9.65% | -14.02% |
| 2017 | -1.50% | 57.02% |
APLSDividend History
Apellis Pharmaceuticals, Inc. doesn't pay dividends
APLSDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
APLSWorst Drawdowns
The table below shows the maximum drawdowns of the Apellis Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Apellis Pharmaceuticals, Inc. is 61.77%, recorded on Oct 24, 2018. It took 216 trading sessions for the portfolio to recover.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -61.77% | Apr 17, 2018 | 134 | Oct 24, 2018 | 216 | Sep 5, 2019 | 350 |
| -59.6% | Feb 11, 2020 | 25 | Mar 17, 2020 | 174 | Nov 20, 2020 | 199 |
| -55.99% | Jul 6, 2021 | 83 | Oct 29, 2021 | — | — | — |
| -43.83% | Jan 5, 2018 | 25 | Feb 9, 2018 | 22 | Mar 14, 2018 | 47 |
| -31.32% | Sep 9, 2019 | 17 | Oct 1, 2019 | 67 | Jan 7, 2020 | 84 |
| -28.91% | Jan 11, 2021 | 51 | Mar 24, 2021 | 47 | Jun 1, 2021 | 98 |
| -21.52% | Mar 19, 2018 | 10 | Apr 2, 2018 | 7 | Apr 11, 2018 | 17 |
| -12.47% | Dec 12, 2017 | 2 | Dec 13, 2017 | 6 | Dec 21, 2017 | 8 |
| -8.38% | Dec 9, 2020 | 3 | Dec 11, 2020 | 2 | Dec 15, 2020 | 5 |
| -8.03% | Jun 15, 2021 | 2 | Jun 16, 2021 | 11 | Jul 1, 2021 | 13 |
APLSVolatility Chart
Current Apellis Pharmaceuticals, Inc. volatility is 38.96%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.